EyePoint Pharmaceuticals Inc (EYPT)
11.29
-0.41
(-3.50%)
USD |
NASDAQ |
Nov 05, 10:20
EyePoint Pharmaceuticals Net Income (Annual): -70.80M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -70.80M |
| December 31, 2022 | -102.25M |
| December 31, 2021 | -58.42M |
| December 31, 2020 | -45.39M |
| December 31, 2019 | -56.79M |
| December 31, 2018 | -44.72M |
| June 30, 2018 | -53.17M |
| June 30, 2017 | -18.48M |
| June 30, 2016 | -21.55M |
| June 30, 2015 | 6.347M |
| June 30, 2014 | -13.36M |
| June 30, 2013 | -11.90M |
| Date | Value |
|---|---|
| June 30, 2012 | -24.84M |
| June 30, 2011 | -8.628M |
| June 30, 2010 | 8.753M |
| June 30, 2009 | -2.511M |
| June 30, 2008 | -75.67M |
| June 30, 2007 | -103.68M |
| June 30, 2006 | -20.91M |
| June 30, 2005 | -12.75M |
| June 30, 2004 | -2.560M |
| June 30, 2003 | -1.858M |
| June 30, 2002 | -2.252M |
| June 30, 2001 | -0.4346M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-102.25M
Minimum
2022
-45.39M
Maximum
2020
-66.73M
Average
-58.42M
Median
2021
Net Income (Annual) Benchmarks
| Cassava Sciences Inc | -97.22M |
| Adverum Biotechnologies Inc | -117.16M |
| Regenxbio Inc | -263.49M |
| Editas Medicine Inc | -153.22M |
| Apellis Pharmaceuticals Inc | -528.63M |